Program - Society of Toxicology

More documents

Recommendations

Info

50 th Anniversary Annual Meeting and ToxExpo Abstract Key Word Index (Continued) The numerals following each key word refer to the relevant abstract number(s). Key Word Index flow cytometry................. 331, 339, 650, 651, 748, 1143, 1144, 1412, 1431, 1445, 1608, 1910 flow-through diffusion cell............... 634 Fluojade B...................................... 2037 fluorescent zebrafish....................... 1614 Fluoride........................................... 2201 fluoxetine........................................ 2398 FMO3............................................. 1088 Focal adhesion kinase..................... 1387 Follicle........................ 1033, 1035, 1036 folliculogenesis............................... 1072 Folpet.............................................. 2260 Food.................... 882, 1252, 2120, 2416 food additive........................... 325, 2630 food additives................................... 155 food allergy............... 89, 96, 1139, 2080 Food animals.................................... 710 Food contaminant............................. 627 food defense.......................... 2432, 2433 food deprivation.............................. 2185 food ingredient................................ 2438 Food Ingredients............................. 2440 Food Nutrition................................ 2429 food safety....... 1525, 1688, 2415, 2427, 2434 foodborne pathogens...................... 2413 Formaldehyde............ 1683, 1690, 1719, 1944, 1945, 1946, 1947, 1948, 1949, 2301, 2558, 2651 formaldehyde dehydrogenase........... 798 Formulation.......................... 2050, 2442 FOXA1............................................. 371 FOXI1............................................. 1602 foxq1............................................... 1631 Fractional Exhaled Nitric Oxide..... 1212 Fragrance........................................ 1034 free fatty acids................................ 1301 free radicals.................. 685, 1296, 1512 frontal cortex.................................. 2146 fructose........................................... 1086 Fry..................................................... 953 FSH................................................. 2398 FT-ICR-MS..................................... 1291 Fuel................................................. 2304 fullerene................................ 1194, 2576 fullerenes........................................ 2161 fumonisin........................................ 1448 Fumonisins..................................... 2425 function........................................... 1729 functional assay.............................. 1142 functional measurements................ 1912 Functional observational battery.... 1549 Functional Toxicogenomics............ 2558 functionalization................... 2076, 2165 Fundulus....................... 318, 1776, 2546 Fundulus heteroclitus..................... 2007 Fungi............................................... 2399 furan........................................ 972, 1417 future................................................. 922 FXR................................................ 1104 GABA............................................. 2140 GADD45a............................... 317, 1414 GAL4/UAS-enhancer trap.............. 1467 Galantamine.................................... 2034 galectin-3.......................................... 457 gallstones........................................ 1113 Gamma Imaging............................... 552 Gap junction................................... 2637 gas dosimetry.................................. 2290 gaseous anesthetic.......................... 1661 gasoline emissions.......................... 2610 Gastrointestinal..................... 1427, 2165 Gastrointestinal Toxicity........... 542, 792 GC/MS............................................ 1695 gemfibrozil..................................... 1890 Gender difference........................... 2254 gene drug disease relationships...... 1737 gene environment interaction........ 1773, 1985 gene expression....................... 119, 124, 126, 131, 196, 255, 380, 381, 591, 813, 820, 993, 1096, 1157, 1177, 1383, 1415, 1457, 1470, 1503, 1594, 1598, 1639, 1853, 2059, 2091, 2110, 2145, 2183, 2239, 2371, 2524, 2597 gene expression profile................... 1590 Gene expression profiling...... 135, 2052, 2318 gene expression, gene regulation...... 413 gene network.................................... 131 gene networks................................. 2322 gene profiling.................................. 1011 gene regulation........ 365, 369, 376, 378, 1135, 1429, 1847, 1851, 2534 Gene Signaling............................... 2092 gene signature................................. 1587 gene silencing................................. 1153 gene therapy...................................... 382 Gene transfection............................ 2526 gene-environment............................. 292 Generic drug..................................... 805 Genes and Environment................. 1769 genetic............................................... 842 Genetic analysis................................ 962 Genetic differences............................. 63 genetic polymorphism.................... 1979 genetic polymorphisms................... 1270 genetic regulation............................. 374 genetic susceptibility.............. 550, 1392 Genetic Toxicity............................... 273 Genetic toxicology........................ 11, 32 Genetic Variability............................ 142 Genetically Modified Bacteria....... 2440 Genetics.......................................... 1367 geniposide....................................... 1827 genistein...................... 2010, 2311, 2361 genome duplication........................ 1775 Genomic........................................... 876 genomic marker.............................. 1561 genomics............. 442, 1601, 1717, 2090 genotoxic........................................ 1950 Genotoxic impurities........................ 152 Genotoxicity.............. 59, 116, 119, 238, 279, 280, 281, 282, 283, 317, 322, 324, 327, 328, 330, 331, 332, 333, 340, 343, 918, 997, 1003, 1005, 1180, 1359, 1403, 1405, 1410, 1412, 1414, 1415, 1419, 1420, 1422, 1469, 1918, 2027, 2075, 2115, 2238, 2575 genotoxicity and genomics............. 2652 genotoxin........................................ 1429 Genotyping..................................... 1369 gentoxicity........................................ 318 germ cells........................................ 1657 Gestation......................................... 1031 gestation/lactation................... 706, 2104 Gestational Exposure...................... 1032 Gestational Membranes.................. 2563 GHS classification............................ 645 GILZ................................................. 200 Gini Coefficient.............................. 1815 ginseng.............................................. 968 Glia........................................... 178, 180 Global Chemicals Management..... 1310 Global Chemicals Policy................ 1310 Global Health.......................... 831, 2589 glucocorticoid........................... 200, 886 Glucosamine................................... 1893 Glutamate......... 1401, 1513, 2025, 2625 glutamate cysteine ligase................ 1280 glutamate transporter........................ 394 glutamine transporter...................... 2131 Glutathione.............................. 258, 259, 425, 752, 1106, 1193, 1308, 1421, 1778, 1835, 2328, 2514, 2621 Glutathione conjugates................... 2319 Glutathione S-Transferases............... 388 glutathione-depletion...................... 2327 glutathione-s-transferase................. 1447 glycation end products...................... 391 glyceraldehyde-3-phosphate dehydrogenase................................ 1305 Glycogen......................................... 1620 glycolytic rate................................. 2528 Glycosylation.................................. 1084 Glyphosate...................................... 2108 Glyphosate herbicides.......... 1073, 1356 Glyphosate-surfactant herbicides... 2114 GMO foods..................................... 1732 GnRH.............................................. 2354 gold nanoparticles...... 1051, 1479, 2059, 2074, 2174 Göttingen minipig................... 559, 1623 GPER.............................................. 1634 G-protein coupled receptor (GPCR)........................................... 2343 gpt assay......................................... 1405 gpt delta transgenic rat.................... 1403 Graduate education......................... 1876 Grant............................................... 1768 green chemistry............... 497, 908, 909, 910, 911, 912, 913 green engineering............................. 909 Green Tea Polyphenols................... 2204 GreenScreen HC............................. 1414 Growth............................................ 1067 growth faltering................................ 832 GSH.................................................. 753 GSNO reductase............................... 798 GST................................................. 1982 GST polymorphisms....................... 2112 GSTs............................................... 1362 GT-094.............................................. 220 guideline........................................... 471 Guideline Studies............................ 2107 guidelines.............................. 1256, 2467 Guinea Pig............................ 2034, 2035 Gulf of Mexico......................... 825, 826 Gum Guggul................................... 2234 GWAS................................................. 43 gynecological.................................. 2374 H295R................................... 2351, 2547 H2A histone.................................... 2205 H9C2, glucose, galactose................. 973 H9c2s.............................................. 1908 Haber’s Rule..................................... 572 haematology................................... 2230 hair.................................................. 1238 hairless guinea pig.......................... 2013 Halfnium Oxide.............................. 1477 Haloacetates.................................... 1099 Halogenated aromatic hydrocarbons.................................... 924 Haloperidol..................................... 1615 Hands-on............................... 1867, 1868 Hanford Miniature Swine................. 636 haplotype........................................ 1360 harm reduction................................ 2694 harmonization........................... 418, 495 hazard assessment............................. 497 hazard categorization...................... 1519 Hazard characterization.................. 1945 hazard classification....................... 1521 hazard identification................. 903, 907 HCS................................................ 1889 HCV.................................................. 447 HDAC............................................... 690 HDAC inhibitors.............................. 948 HDAC6........................................... 1279 HDO................................................. 556 health................ 922, 923, 924, 925, 926 health and safety............................. 1517 health effects................................... 1223 health guidance value..................... 1811 health guidance values.................... 2298 Health Monitoring Data.................. 1199 health risk assessment............. 597, 2292 hearing loss....................................... 160 heart.... 203, 213, 442, 1647, 2008, 2359 Heart failure...................... 196, 208, 214 Heart rate.................... 1166, 1487, 1645 Heart Rate Variability....................... 596 Heart Regeneration................... 197, 198 heart slices...................................... 1907 Heat Shock Protein................. 395, 1750 heat stability.................................... 2431 Heatox............................................... 882 heavy metal....................................... 295 Heavy metals........................ 1223, 1605 hedgehog signaling pathway.......... 1631 helicobacter pylori.......................... 2650 Hematologic toxicity........................ 509 Hematological Effects.................... 1473 hematopoietic progenitor cells....... 1168 hematopoietic stem cell........ 1153, 1158 Hematopoietic stem cells...... 1157, 1500 hematotoxicity............ 1557, 1949, 2340 heme oxygenase-1.......................... 2216 hemochromatosis.............................. 511 Hemodynamics................................. 559 Hemoglobin.................................... 2320 Hemorrhagic shock/ Resuscitation................................... 1648 hemostasis....................................... 2047 hemostatic system................... 433, 2022 HepaRG................ 420, 935, 1903, 2516 HepaRG cells.................................. 1579 Heparin............................................. 440 Hepatic and renal toxicity............... 2222 Hepatic cells................................... 1097 Hepatic fibrosis............................... 2212 hepatic gene expression.................. 1584 hepatic steatosis.............................. 1117 Hepatic stellate cells....................... 2212 hepatic toxicity..................... 2522, 2523 Hepatic transporters.......................... 534 Hepatitis C........................................ 690 Hepatocarcinogenesis..................... 2657 hepatocellular carcinoma...... 1096, 1674 Hepatocyte.................... 429, 1098, 1173 hepatocytes.......... 311, 366, 1822, 1864, 2349, 2537, 2557 Hepatoprotective effect................... 2224 Hepatotoxicants................................ 532 hepatotoxicity.................. 139, 397, 420, 421, 424, 427, 428, 432, 434, 443, 444, 445, 448, 451, 454, 459, 805, 941, 995, 1089, 1119, 1173, 1269, 1577, 1590, 1678, 1705, 1710, 1735, 1834, 1899, 1905, 2418, 2539, 2540 hepatotoxins...................................... 426 hepatoxicity.................................... 2561 hepcidin............................................ 511 HepG2........................... 422, 1162, 1841 HepG2 cells.......................... 1667, 2531 Heptachlor.......................................... 98 Heptototoxicity....................... 437, 1966 herbal.............................................. 2631 herbal supplement................. 2374, 2439 herbicide diuron................................ 547 Hexabromocyclododecane............. 1252 hexachlorobenzene............... 1358, 2685 hexahydro-1, 3, 5-trinitro-1, 3, 5-triazine....................................... 736 Hexavalent chromium..... 278, 915, 916, 917, 918, 920, 921, 2407 hexavalent chromium (CrVI)......... 1597 HGF................................................ 1112 HIF-1.............................................. 1652 high content.................................... 2540 High Content Analysis...................... 420 high content cell-based imaging........ 28, 31, 2511 High Content Image Analysis.......... 398, 2629 high content imaging.................... 29, 32 High Content Screening.......... 33, 1895, 1966 High Content Screening Assay....... 1903 392 SOT 50th Anniversary Annual Meeting
Society of Toxicology 2011 Abstract Key Word Index (Continued) The numerals following each key word refer to the relevant abstract number(s). High Definition Oscillometry........... 561 high fat diet........................... 2002, 2213 High Performance Metabolic Profiling.......................................... 1257 High Throughput................... 316, 1813, 1894, 2553 high throughput screening........ 333, 369 High throughput toxicity testing......... 13 high-content screening assay.......... 1889 high-throughput................................ 982 High-throughput assay.................... 2121 High-throughput Screening........... 1760, 2505 hippocampus..... 1375, 1390, 2145, 2146 hiring............................................... 2486 Histiotrophic nutrition.................... 1616 histone acetyltransferase................... 107 histone H2AX................................... 878 histone modification..... 815, 1019, 2497 Histone Modifications.............. 946, 950 histopathology.................... 58, 560, 648 historical......................................... 2437 Historical Control Data................... 1028 history............. 923, 924, 925, 926, 1880 history of safe use........................... 1728 HIV gp120........................................ 677 HIV HLA........................................ 1364 HIV infection.................................... 612 HIV therapy.................................... 1275 HIV-antiretrovirals............................ 613 HLA-specific.................................. 1498 HMGB1.......................... 263, 264, 2337 HMGCoA reductase......................... 789 HMG-CoA Reductase Inhibitor...... 1630 HNE.................................................. 262 HNSCC............................................. 363 HO-1............................................... 2127 Homologous Recombination............ 114 Homology modeling......................... 368 Host defense................................... 1474 Host resistance................................ 1129 Hot flashes...................................... 1219 house dust....................................... 1229 Housekeeping Gene Expression..... 1753 Hovenia dulcis extract.................... 2224 HPA axis............................... 1699, 2151 HPLC/MS/MS................................ 1689 HPLC-MS/MS................................ 1428 HR96............................................... 2382 Hras................................................... 357 hRPTC............................................ 2544 HSP70............................................... 166 Hsp70 and liver............................... 2199 HSP90............................... 214, 793, 804 HTS................................................... 340 human........ 474, 981, 1847, 1959, 1961, 2259 Human biotransformation............... 2097 human bladder epithelial................ 1977 Human blood plasma...................... 2244 human bronchoalveolar H358 cells....................................... 1681 human embryonic stem cells.......... 1167 human epidermal keratinocytes...... 1176 human exposure level....................... 435 Human Growth Hormone............... 1156 human health risk assessment........ 1229, 1266 human health risks.......................... 1245 Human Hepatocytes...... 381, 1094, 2096 human keratinocyte cell line.......... 1011, 2059 human kinetic adjustment factor..... 500, 501 human liver slices........................... 2561 human lung cells............................. 1831 human lymphocytes.......................... 326 human metabolism................ 1823, 1824 human neural progenitor cells.......... 870 Human Peripheral Blood Lymphocytes..................................... 334 human placenta............................... 2169 human plasma................................. 2195 human primary hepatocytes.............. 859 Human Relevance........................... 1933 human renal proximal tubule cells... 762 human skin equivalents.................. 1012 human stem cell.............................. 2455 human stem cell-derived cardiomyocyte................................ 1165 human THP-1 macrophages........... 2053 human variability.............................. 821 humanized mAb.............................. 1929 humoral immunity............................ 678 Huntington’s disease............. 2121, 2132 huperzine A..................................... 2585 HUVECs......................................... 1999 hydrocarbons.................................. 2316 hydrofluorocarbon.......................... 2259 hydrogen peroxide.......................... 1532 Hydrogen Sulfide............................ 1214 hydroquinone.................................. 1673 hydroxyl radicals............................ 1292 hydroxylated fullerene nanoparticles................................... 1176 hydroxylated PBDEs...................... 1607 Hypercholesterolemia..................... 1113 hypercholesterolemic...................... 1112 hyperoxia.... 261, 264, 1856, 2193, 2587 hypersensitivity.......... 83, 470, 620, 667, 989, 1497, 1498, 2422 Hypertension................... 199, 554, 2008 Hyperthyroidism............................. 2353 hypertrophy....................................... 207 Hypotension...................................... 778 hypothalamic peptide...................... 2343 hypothalamic-pituitary-thyroid......... 702 Hypothalamus....................... 1063, 2354 Hypothesis Generation..................... 480 Hypothyroidism.............................. 2353 hypoxia........................................... 1652 IATA................................................ 1539 ICAM-1............................................ 259 ICH S6............................................ 1912 ICH S9............................................ 1912 ID gene............................................. 445 idiosyncratic drug reactions..... 424, 509, 1499, 1501, 1504 Idiosyncratic Hepatotoxicity........... 936, 1014, 1658 Idiosyncratic Liver Toxicity............. 510 IE-Cpr-Null..................................... 2264 IFN-gamma....................................... 694 IgE................................ 530, 2080, 2207 IgE antibody..................................... 903 IgE+ B lymphocytes......................... 530 IGF-1........................................ 351, 407 IGF-1R.................................... 788, 2315 IL-1 Beta............................... 1040, 1617 IL-12................................................. 796 IL-18............................................... 2571 IL-1b................................................... 57 IL-2................................................... 345 IL-23................................................. 796 IL-33............................................... 1514 IL-6........................................... 441, 442 IL-7................................................. 1502 ILSI................................................. 1525 image................................................ 448 Image analysis................................ 2615 Imaging................................... 429, 2618 immune cells......................... 1141, 1891 Immune function.............................. 658 immune monitoring for latent viruses............................................. 1148 Immune regulation.................... 680, 949 immune response............................ 2042 immune responses.............................. 23 immune suppression............... 678, 1013 immune system............................... 1189 immune tolerance........................... 1502 immune-competent cells................. 2052 Immune-mediated toxicity.............. 2686 immune-modulating....................... 2083 Immunodeficient mice.................... 1512 immunodevelopment........................ 630 immunogenicity.................... 1150, 1151 Immunoglobulin regulation............ 1124 Immunohistochemistry..................... 881 immunolocalization.......................... 575 immunological mechanisms............. 902 immunology.................. 657, 1126, 2446 immunomodulation................. 698, 1169 Immunomodulator............................ 692 Immunomodulatory compounds..... 1140 immunopathology........................... 1709 Immunophenotyping................ 528, 529, 650, 651 immunosuppression........... 80, 652, 659, 667, 675, 676, 1133, 1189 immunotoxic..................................... 695 immunotoxicity........................ 185, 649, 650, 654, 659, 661, 663, 667, 670, 679, 682, 691, 1125, 1131, 1133, 1140, 1145, 1146, 1628, 1988, 1989 Immunotoxicity testing..................... 664 immunotoxicology........... 287, 571, 653, 655, 673, 1143, 1147, 1148, 1152, 1504, 2422, 2682, 2685 impedance....................................... 2344 Implant.................................................. 1 Imposex................................ 1068, 2393 improved catheter dosing............... 1913 in ovo.............................................. 1684 in silico....... 157, 469, 1559, 2679, 2681 in silico analysis............................... 132 in silico model.......................... 137, 464 in silico prediction.................... 496, 855 In situ perfusion.............................. 1377 in utero............................................ 1612 in utero exposure.......... 616, 1055, 1069 in vitro...... 640, 803, 850, 939, 969, 978, 982, 990, 1002, 1020, 1023, 1354, 1539, 1553, 1650, 1671, 1821, 1888, 1908, 1966, 2070, 2167, 2303, 2454, 2463, 2516, 2543, 2544, 2550, 2554, 2629, 2678, 2679 in vitro-in vivo extrapolation............. 13, 715, 1975 in vitro airway model...................... 1003 in vitro alternative........................... 2373 in vitro Alternative Method...... 87, 1010 in vitro Alternatives...... 998, 1528, 2032 in vitro Animal Alternative Method.................................. 1049, 1555 in vitro assay......................... 1000, 2540 in vitro assays..................................... 28 in vitro biliary clearance................. 1081 in vitro cornea model........... 2031, 2032, 2033 in vitro cytotoxicity.... 1021, 1234, 2226 in vitro developmental neurotoxicity testing....................... 2518 in vitro drug testing............... 1165, 1899 in vitro evaluation platform............ 2158 in vitro Gastrointestinal Model....... 2572 in vitro human skin model................ 647 in vitro Human Skin Models......... 2541, 2542 in vitro-in vivo correlation...... 856, 2348 in vitro-in vivo extrapolation............ 733 in vitro method comparison.............. 565 in vitro Methodology........................ 905 in vitro methods.................................. 14 in vitro methylation........................ 1981 in vitro Micronucleus................ 32, 2162 in vitro micronucleus assay.............. 343 in vitro model............. 1009, 1902, 2370, 2513, 2519 In vitro model for inhalation............ 983, 2567 in vitro model for vapor exposure.......................................... 2304 in vitro models........................ 430, 1766 in vitro neurotoxicity.......................... 31 in vitro prediction..................... 317, 935 in vitro screening........... 717, 996, 1897, 2564, 2680 in vitro skin..................................... 2574 in vitro skin irritation.............. 467, 2555 in vitro skin model...... 2534, 2571, 2575 in vitro skin sensitization test... 85, 2560 in vitro test...................................... 1010 in vitro testing..... 739, 1905, 2470, 2480 in vitro toxicity assays......... 1094, 1889, 1903 in vitro Toxicology................. 534, 1606 in vivo..... 1045, 1470, 1562, 2234, 2261 in vivo alternative............................. 341 in vivo comet/micronucleus combination.................................... 1481 in vivo gene mutation...................... 2632 in vivo imaging............................... 2674 in vivo micronucleus....................... 1416 in vivo model.................................. 1018 in vivo mutation...................... 879, 1416 inbred mouse strain........................... 822 Indirubin........................................... 416 Indium particles................................ 578 individualized prevention strategies... 46 indoles............................................. 1507 indoor.............................................. 1244 indoor air pollutant biomonitoring... 977 Indoor Air Quality...... 1214, 1215, 1573 Indoor dust...................................... 1268 indoor mold...................................... 174 Induced Pluripotent Stem Cell......... 215, 1173, 2453 induced pluripotent stem cells....... 1167, 2451 inducible nitric oxide synthase......... 684 Infants............................................. 1060 inflammasome.............. 27, 35, 55, 1711 Inflammation....... 55, 61, 217, 218, 238, 254, 314, 416, 452, 539, 599, 643, 668, 669, 756, 901, 1091, 1105, 1128, 1134, 1294, 1462, 1709, 1780, 1782, 1784, 1785, 1997, 2028, 2127, 2181, 2190, 2205, 2323, 2331, 2446 inflammatory bowel disease..... 36, 1133 inflammatory bowel diseases........... 364 Inflammatory cytokines.................. 1570 inflammatory response..................... 573 inflammatory responses...................... 25 influenza......................................... 1132 Informatics........................................ 419 infusion models.............................. 1931 Ingenuity Pathway Analyses............... 26 Inhalation......... 290, 540, 563, 564, 589, 594, 599, 601, 605, 1152, 1196, 1458, 1546, 1570, 1755, 1762, 1882, 1954, 2012, 2475, 2476, 2493 Inhalation dose.................................. 572 Inhalation elicitation threshold......... 904 Inhalation exposure..... 588, 1471, 2029, 2610 inhalation exposures....................... 2338 Inhalation nanotoxicology.............. 1466 Inhalation Risk Assessment.............. 587 Inhalation Safety Assessment.......... 585, 587 Inhalation study.............................. 1459 inhalation toxicity....... 1547, 2057, 2567 Inhalation toxicology........... 53, 58, 585, 586, 587, 1468 Inhaled.................................. 1883, 2058 inhibition......................................... 1844 initiation/promotion................ 237, 2630 Injection.......................................... 1902 Key Word Index up-to-date information at www.toxicology.org 393
Page 1 and 2:
50 th Anniversary Annual Meeting &
Page 3 and 4:
Scientific Program Overview A page
Page 5 and 6:
9:00 AM-12:30 PM POSTER SESSionS
Page 7 and 8:
March 6-10, 2011 Walter E. Washingt
Page 9 and 10:
Celebration Activities Historical H
Page 11 and 12:
of the Society Regional Chapter Yea
Page 13 and 14:
SOT Presidents 1961-2011 1966 1967
Page 15 and 16:
The SOT Council Thanks and Recogniz
Page 17 and 18:
of the Past 50 Years 2003 Michael D
Page 19 and 20:
Thank You to the following individu
Page 21 and 22:
SOT Celebration Event Floor Plan Ba
Page 23 and 24:
50 th Anniversary Annual Meeting an
Page 25 and 26:
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Page 27 and 28:
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Page 29 and 30:
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Page 31 and 32:
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Page 33 and 34:
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Page 35 and 36:
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Page 37 and 38:
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Page 39 and 40:
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Page 41 and 42:
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Page 43 and 44:
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Page 45 and 46:
Toxicological Sciences The Official
Page 47 and 48:
Society of Toxicology 2011 Walter E
Page 49 and 50:
Society of Toxicology 2011 Washingt
Page 51 and 52:
Society of Toxicology 2011 Map of W
Page 53 and 54:
2011 SOT 50 th Anniversary Featured
Page 55 and 56:
Society of Toxicology 2011 Washingt
Page 57 and 58:
Society of Toxicology 2011 ToxExpo
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Society of Toxicology 2011 Exhibito
Page 65 and 66:
Creating a Safer and Healthier Worl
Page 67 and 68:
Society of Toxicology 2011 General
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
SOT Job Bank YOUR RECRUITMENT AND E
Page 83 and 84:
Society of Toxicology 2011 Career R
Page 85 and 86:
Society of Toxicology 2011 SOT 2011
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Society of Toxicology 2011 2011 Awa
Page 95 and 96:
Endowment Awardees for SOT’s 50 t
Page 97 and 98:
Society of Toxicology 2011 SOT Endo
Page 99 and 100:
Society of Toxicology 2011 Recognit
Page 101 and 102:
Society of Toxicology 2011 Recognit
Page 103 and 104:
Society of Toxicology 2011 RC, SIG,
Page 105 and 106:
Society of Toxicology 2011 Student
Page 107 and 108:
Society of Toxicology 2011 Outreach
Page 109 and 110:
Society of Toxicology 2011 Satellit
Page 111 and 112:
Society of Toxicology 2011 Continui
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Society of Toxicology 2011 Scientif
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Society of Toxicology 2011 Poster S
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Society of Toxicology 2011 Program
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
Page 357 and 358:
Page 359 and 360:
Page 361 and 362:
Page 363 and 364: Society of Toxicology 2011 Program
Page 381 and 382: Society of Toxicology 2011 Author I
Page 409 and 410: Society of Toxicology 2011 Abstract
Page 413: Society of Toxicology 2011 Abstract
Page 425 and 426: Society of Toxicology 2011 2010-201
Page 427 and 428: Society of Toxicology 2011 Elected
Page 429 and 430: Society of Toxicology 2011 Elected
Page 431 and 432: Society of Toxicology 2011 Regional
Page 433 and 434: Society of Toxicology 2011 Specialt
Page 435 and 436: Society of Toxicology 2011 Specialt
Page 437 and 438: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
Page 439 and 440: Society of Toxicology 2011 Endowmen
Page 447 and 448: Society of Toxicology 2011 SOT Affi
Page 449 and 450: Society of Toxicology 2011 Notes up
Page 451 and 452: Society of Toxicology 2011 Notes up
Page 453 and 454: Society of Toxicology 2011 Headquar
Page 455 and 456: QUICK REFERENCE Visit www.mwata.com
show all

Program - Society of Toxicology

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?